Nicotinamide

Claramunt-Taberner D, et al. Hyperphosphatemic tumoral calcinosis caused by FGF23 compound heterozygous mutations: what are the therapeutic options for a better control of phosphatemia?. Pediatric Nephrology 33: 1263-1267, No. 7, Jul 2018. Available from: URL: http://doi.org/10.1007/s00467-018-3945-z -FranceCrossRefPubMedGoogle Scholar